Patents by Inventor Julie A. Morrow

Julie A. Morrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APOLIPOPROTEIN E STABLE FOLDING INTERMEDIATE AND METHODS OF USE THEREOF
    Publication number: 20090017558
    Abstract: The present invention provides isolated apolipoprotein E (apoE) stable folding intermediates. The invention further provides methods for identifying compounds that alter the structure or level or activity of an apoE stable folding intermediate, as well as methods of inhibiting the formation or activity of stable folding intermediates of apoE. The invention further provides methods for reducing the level and/or activity of an apoE stable folding intermediate, and methods for treating disorders relating to apoE4 in a subject.
    Type: Application
    Filed: August 27, 2008
    Publication date: January 15, 2009
    Inventors: KARL H. WEISGRABER, Julie A. Morrow
  • Apolipoprotein E stable folding intermediate and methods of use thereof
    Patent number: 7432355
    Abstract: The present invention provides isolated apolipoprotein E (apoE) stable folding intermediates. The invention further provides methods for identifying compounds that alter the structure or level or activity of an apoE stable folding intermediate, as well as methods of inhibiting the formation or activity of stable folding intermediates of apoE. The invention further provides methods for reducing the level and/or activity of an apoE stable folding intermediate, and methods for treating disorders relating to apoE4 in a subject.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: October 7, 2008
    Assignee: The J. David Gladstone Institutes
    Inventors: Karl H. Weisgraber, Julie A. Morrow
  • Apolipoprotein E stable folding intermediate and methods of use thereof
    Publication number: 20040228851
    Abstract: The present invention provides isolated apolipoprotein E (apoE) stable folding intermediates. The invention further provides methods for identifying compounds that alter the structure or level or activity of an apoE stable folding intermediate, as well as methods of inhibiting the formation or activity of stable folding intermediates of apoE. The invention further provides methods for reducing the level and/or activity of an apoE stable folding intermediate, and methods for treating disorders relating to apoE4 in a subject.
    Type: Application
    Filed: July 23, 2003
    Publication date: November 18, 2004
    Inventors: Karl H. Weisgraber, Julie A. Morrow